Business Context and Reporting Period
This Form 8-K Current Report was filed by National Healthcare Properties, Inc. on December 20, 2024. The filing primarily addresses the execution of a new employment agreement with the Chief Financial Officer and the declaration of dividends on the Company's preferred stock classes.
Key Financial Metrics and Compensation Details
The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the reporting period. However, it discloses specific compensation figures and dividend declarations:
- CFO Base Salary: $425,000 annually (effective January 1, 2025).
- CFO Target Annual Bonus: 100% of base salary ($425,000), with a guaranteed minimum for fiscal year 2025.
- CFO Long-Term Incentives (2025): Target grant date fair value of no less than $800,000.
- CFO One-Time Award: Grant date fair value of $1.0 million.
- Preferred Stock Dividends:
- 7.375% Series A: $0.4609375 per share.
- 7.125% Series B: $0.4453125 per share.
Material Changes and Agreements
The primary material change is the new employment agreement with Scott Lappetito, effective January 1, 2025. Key terms include:
- Equity Structure: Awards are contingent on shareholder approval of an omnibus equity plan and the listing of Common Stock on a public exchange. If these conditions are not met, equity awards convert to deferred cash awards.
- Vesting: Long-term awards vest ratably over three years.
- Severance Provisions:
- Without Cause/Good Reason (Standard): 1.0x sum of base salary and target bonus paid over 24 months, plus accelerated vesting of time-based awards and 18 months of healthcare reimbursement.
- Without Cause/Good Reason (Change in Control): 2.0x sum of base salary and target bonus paid in a lump sum within 60 days.
Outlook, Risks, and Contingencies
The filing highlights significant contingencies regarding the Company's capital structure and executive compensation:
- Listing Contingency: The form of the CFO's equity compensation (stock vs. cash) depends entirely on the successful listing of Common Stock on a public exchange and shareholder approval of the equity plan in fiscal year 2025.
- Dividend Payment: Dividends on Series A and Series B preferred stock are payable on January 15, 2025, to holders of record as of January 3, 2025.
- Regulatory Disclosure: The dividend announcement is furnished under Regulation FD and is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the status of the Company's Common Stock listing application and the timeline for the 2025 Annual Shareholder Meeting.
- Confirm the approval status of the omnibus equity incentive plan required to grant the CFO's stock-based awards.
- Review the Company's liquidity position to ensure it can meet the January 15, 2025, preferred stock dividend obligations.
- Assess the potential cash impact of the CFO's deferred cash award alternative if the equity plan is not approved or the stock is not listed.